• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroSense Therapeutics Ltd. - Ordinary Shares (NQ:NRSN)

1.080 -0.720 (-40.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,585,218
Open 1.750
Bid (Size) 1.060 (50)
Ask (Size) 1.170 (1)
Prev. Close 1.800
Today's Range 1.000 - 1.774
52wk Range 0.5985 - 2.600
Shares Outstanding 23,228,941
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
August 01, 2025
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
These stocks are moving in today's session
August 01, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
-6.1%
-6.1%
1 Month
-43.5%
-43.5%
3 Month
+0.9%
+0.9%
6 Month
-8.5%
-8.5%
1 Year
+46.3%
+46.3%

More News

Read More
The market is filled with gapping stocks in Friday's session.
August 01, 2025
Via Chartmill
NeuroSense Inches Closer to Pharma Partnership as Canadian Regulatory Progress Turns Heads
June 26, 2025
Via News Direct
Topics Regulatory Compliance
Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights
May 12, 2025
Via Benzinga
This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
May 12, 2025
Via Benzinga
NeuroSense Therapeutics is on Verge of Potential Blockbuster Pharma Deal as ALS Drug Shows 58% Survival Improvement
April 24, 2025
Via News Direct
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
March 20, 2025
From Market News Alerts
Via Business Wire
Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
March 19, 2025
Via News Direct
Topics Regulatory Compliance
PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
March 17, 2025
From PESG Research
Via Business Wire
EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
October 28, 2024
Via Benzinga
NeuroSense Advances Plans For Early Commercialization Of Potentially Groundbreaking ALS Treatment In Canada, Targeting A $100M+ Market
October 17, 2024
Via News Direct
EXCLUSIVE: NeuroSense Therapeutics In Advanced Talks With Several Multi-Billion-Dollar Pharma Companies To Partner Its Lead Drug
August 28, 2024
Via Benzinga
NRSN Stock Earnings: NeuroSense Therapeutics Misses EPS for Q1 2024
June 24, 2024
Via InvestorPlace
NRSN Stock Earnings: NeuroSense Therapeutics Beats EPS for Q4 2023
April 05, 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 15, 2024
Via InvestorPlace
NeuroSense's (NASDAQ: NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
January 29, 2024
Via Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
Via Benzinga
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
Via Benzinga
Topics Stocks
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
December 06, 2023
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 06, 2023
Via InvestorPlace
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Via Benzinga
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
December 05, 2023
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 05, 2023
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
November 17, 2023
Via InvestorPlace

Frequently Asked Questions

Is NeuroSense Therapeutics Ltd. - Ordinary Shares publicly traded?
Yes, NeuroSense Therapeutics Ltd. - Ordinary Shares is publicly traded.
What exchange does NeuroSense Therapeutics Ltd. - Ordinary Shares trade on?
NeuroSense Therapeutics Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroSense Therapeutics Ltd. - Ordinary Shares?
The ticker symbol for NeuroSense Therapeutics Ltd. - Ordinary Shares is NRSN on the Nasdaq Stock Market
What is the current price of NeuroSense Therapeutics Ltd. - Ordinary Shares?
The current price of NeuroSense Therapeutics Ltd. - Ordinary Shares is 1.080
When was NeuroSense Therapeutics Ltd. - Ordinary Shares last traded?
The last trade of NeuroSense Therapeutics Ltd. - Ordinary Shares was at 08/01/25 04:00 PM ET
What is the market capitalization of NeuroSense Therapeutics Ltd. - Ordinary Shares?
The market capitalization of NeuroSense Therapeutics Ltd. - Ordinary Shares is 25.09M
How many shares of NeuroSense Therapeutics Ltd. - Ordinary Shares are outstanding?
NeuroSense Therapeutics Ltd. - Ordinary Shares has 25M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap